Superoxide anion release from circulating neutrophils in interstitial pulmonary fibrosis. Study of patients and experimental animal model.:<I>Study of patients and experimental animal model</I>
スポンサーリンク
概要
- 論文の詳細を見る
The superoxide anion (O<SUP>-</SUP><SUB>2</SUB>) release from circulating neutrophils (c-PMN) in interstitial lung diseases, idiopathic interstitial pneumonitis (IIP), sarcoidosis (SA) and rheumatic pneumonitis (RA) was studied. At the same time, we demonstrated that the mechanism of acceleration of phorbol myristate acetate (PMA) -induced O<SUP>-</SUP><SUB>2</SUB> release in c-PMN by using animal model of bleomycin (BLM) -induced lung injury and pulmonary fibrosis. (1) Spontaneous O<SUP>-</SUP><SUB>2</SUB> release was not differ from healthy volunteer group and TIP, RA, SA groups. (2) Time course of PMA-induced O<SUP>-</SUP><SUB>2</SUB> release from c-PMN in TIP was increased significantly compared with that of healthy volunteer, RA and SA groups. (3) f-MLP-induced O<SUP>-</SUP><SUB>2</SUB> release of c-PMN in TIP group was lower than that of healthy volunteer group. (4) On the stage of acute inflammation induced by intratracheal injection of BLM to guinea pigs, f-MLP and alpha-TNF-induced O<SUP>-</SUP><SUB>2</SUB> release from c-PMN in BLM group were increased significantly, but not in spontaneous and PMA stimulation. (5) On the progress stage of BLM-induced fibrosis, various stimulants-induced and spontaneous O<SUP>-</SUP><SUB>2</SUB> release were not differ from saline injected group and BLM group.<BR>These results suggested that c-PMN in IIP patients may affect in pathogenesis of interstitial pulmonary fibrosis which was under the stable stage. And this accelerated PMA-dependent O<SUP>-</SUP><SUB>2</SUB> release could be induced by the change of intracellular signal pathways which transmitted from protein kinase C stimulation to NADPH oxidase activation.
- 日本炎症・再生医学会の論文
日本炎症・再生医学会 | 論文
- 新規キノリノン誘導体TA-270の炎症性気道疾患に対する効果
- Salazosulphapyridine, Predonizolone の好中球機能に及ぼす影響と Sodium ferrous citrate との併用効果についての検討
- Sodium ferrous citrate の好中球機能に及ぼす影響
- Mesalazine(Pentasa) の好中球機能に及ぼす影響と Sodium ferrous citrate(SFC) との併用効果についての検討
- 非ウイルスベクターによる細胞標的法の開発